|
Market Closed -
Euronext Paris
11:55:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 8.300 EUR | -0.95% |
|
+4.27% | +5.33% |
| 08-31 | OXya SAS acquired Xiomega Consulting from Keyrus S.A.. | CI |
| 07-07 | Keyrus S.A. acquired inlumi BV from Nimbus hands-on investors. | CI |
| Fiscal Period: December | 2016 (EUR) | 2017 (EUR) | 2018 (EUR) | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.87 | 2.68 | 2.87 | 2.22 | 0.46 | |||||
Return on Total Capital | 3.4 | 4.93 | 5.31 | 4.22 | 0.89 | |||||
Return On Equity % | 15.7 | 11.19 | 7.95 | 0.66 | 5.52 | |||||
Return on Common Equity | 10.01 | 9.66 | 8.23 | 1.63 | 6.18 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.97 | 7.88 | 7.75 | 6.72 | 5.27 | |||||
EBITDA Margin % | 4.4 | 4.9 | 5.1 | 4.18 | 1.43 | |||||
EBITA Margin % | 3.75 | 4.55 | 4.61 | 3.62 | 1.01 | |||||
EBIT Margin % | 3.29 | 4.09 | 4.31 | 3.39 | 0.73 | |||||
Income From Continuing Operations Margin % | 2.44 | 1.46 | 1.01 | 0.1 | 0.99 | |||||
Net Income Margin % | 1.38 | 1.09 | 0.94 | 0.22 | 1 | |||||
Net Avail. For Common Margin % | 1.38 | 1.09 | 0.94 | 0.22 | 1 | |||||
Normalized Net Income Margin | 1.19 | 1.61 | 1.46 | 1 | -0.83 | |||||
Levered Free Cash Flow Margin | 2.92 | 3.91 | 4.14 | 3.8 | -1.1 | |||||
Unlevered Free Cash Flow Margin | 3.34 | 4.42 | 5.16 | 4.9 | -0.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.91 | 1.05 | 1.06 | 1.05 | 1.01 | |||||
Fixed Assets Turnover | 7.63 | 10.78 | 13.36 | 15.15 | 15.87 | |||||
Receivables Turnover (Average Receivables) | 3.78 | 4.19 | 4.16 | 4.09 | 4.05 | |||||
Inventory Turnover (Average Inventory) | 22.42K | 19.65K | 22.04K | 41.35K | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.93 | 1.03 | 1.01 | 1 | 0.98 | |||||
Quick Ratio | 0.85 | 0.94 | 0.92 | 0.91 | 0.89 | |||||
Operating Cash Flow to Current Liabilities | 0.07 | 0.11 | 0.12 | 0.1 | -0.01 | |||||
Days Sales Outstanding (Average Receivables) | 96.61 | 87.16 | 87.73 | 89.4 | 90.2 | |||||
Days Outstanding Inventory (Average Inventory) | 0.02 | 0.02 | 0.02 | 0.01 | - | |||||
Average Days Payable Outstanding | 48.4 | 47.6 | 45.98 | 43.85 | - | |||||
Cash Conversion Cycle (Average Days) | 48.22 | 39.58 | 41.76 | 45.57 | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 276.39 | 319.22 | 280.3 | 197.75 | 181.08 | |||||
Total Debt / Total Capital | 73.43 | 76.15 | 73.7 | 66.41 | 64.42 | |||||
LT Debt/Equity | 185.74 | 235.66 | 214.85 | 156.54 | 124.24 | |||||
Long-Term Debt / Total Capital | 49.35 | 56.21 | 56.49 | 52.57 | 44.2 | |||||
Total Liabilities / Total Assets | 85.57 | 87 | 85.88 | 82.66 | 81.36 | |||||
EBIT / Interest Expense | 4.94 | 5.05 | 2.64 | 1.92 | 0.52 | |||||
EBITDA / Interest Expense | 10.3 | 8.24 | 4.04 | 3.29 | 1.96 | |||||
(EBITDA - Capex) / Interest Expense | 8.83 | 7.22 | 3.75 | 2.81 | 1.53 | |||||
Total Debt / EBITDA | 6.37 | 6.26 | 5.53 | 5.56 | 11.86 | |||||
Net Debt / EBITDA | 3.92 | 3.61 | 3.37 | 3.31 | 6.85 | |||||
Total Debt / (EBITDA - Capex) | 7.43 | 7.15 | 5.96 | 6.52 | 15.25 | |||||
Net Debt / (EBITDA - Capex) | 4.58 | 4.12 | 3.63 | 3.89 | 8.81 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.83 | 21.68 | 5.24 | -4.25 | -6.45 | |||||
Gross Profit, 1 Yr. Growth % | -13.44 | 37.6 | 3.48 | -17.01 | -26.65 | |||||
EBITDA, 1 Yr. Growth % | 31.79 | 35.32 | 9.67 | -21.5 | -67.97 | |||||
EBITA, 1 Yr. Growth % | 37.72 | 68.43 | 18.51 | -24.69 | -73.84 | |||||
EBIT, 1 Yr. Growth % | 44.95 | 51.26 | 11.02 | -24.79 | -79.72 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 393.21 | -27.08 | -27.04 | -90.72 | 840.23 | |||||
Net Income, 1 Yr. Growth % | -934.38 | -3.84 | -9.22 | -77.47 | 321.84 | |||||
Normalized Net Income, 1 Yr. Growth % | 123.99 | 65.19 | -4.63 | -34.27 | -177.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -931.97 | -4 | -8.91 | -77.47 | 321.76 | |||||
Accounts Receivable, 1 Yr. Growth % | 3.93 | 15.42 | -2.3 | -3.09 | -7.68 | |||||
Inventory, 1 Yr. Growth % | 0 | 75 | -52.38 | -40 | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -16.76 | -10.34 | -20.36 | -9.54 | -11.9 | |||||
Total Assets, 1 Yr. Growth % | -0.52 | 11.78 | -3.52 | -2.26 | -2.5 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.09 | 32.47 | 1.21 | -15.23 | -4.13 | |||||
Common Equity, 1 Yr. Growth % | -4.31 | 3.62 | 9.61 | 18.08 | 4.83 | |||||
Cash From Operations, 1 Yr. Growth % | -77.19 | 55.43 | 8.1 | -19.59 | -105.68 | |||||
Capital Expenditures, 1 Yr. Growth % | -30.33 | 2.82 | -39.19 | 71.33 | -32.15 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -79.53 | 62.86 | 11.44 | -12.22 | -127.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -77.25 | 60.97 | 23.03 | -9.14 | -104.11 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.43 | 16.13 | 13.16 | 0.38 | -5.36 | |||||
Gross Profit, 2 Yr. CAGR % | 11.89 | 9.13 | 19.32 | -7.33 | -21.98 | |||||
EBITDA, 2 Yr. CAGR % | 36.2 | 33.55 | 21.82 | -7.22 | -49.85 | |||||
EBITA, 2 Yr. CAGR % | 46.33 | 42.67 | 33.89 | -5.53 | -55.61 | |||||
EBIT, 2 Yr. CAGR % | 44.81 | 48.07 | 29.59 | -8.63 | -60.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 13.05 | 89.65 | -27.05 | -73.97 | -6.57 | |||||
Net Income, 2 Yr. CAGR % | -18.6 | 183.25 | -6.56 | -54.77 | -2.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | 198.26 | 92.36 | 25.53 | -20.82 | -28.8 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -18.89 | 182.61 | -6.49 | -54.7 | -2.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8.12 | 9.52 | 6.19 | -2.69 | -5.41 | |||||
Inventory, 2 Yr. CAGR % | -57.36 | 32.29 | -8.71 | -46.55 | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.67 | -13.61 | -15.5 | -15.12 | -10.73 | |||||
Total Assets, 2 Yr. CAGR % | 4.8 | 5.45 | 3.85 | -2.89 | -2.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | 88.55 | 29.24 | 15.79 | -7.37 | -9.85 | |||||
Common Equity, 2 Yr. CAGR % | -12.32 | -0.43 | 6.57 | 13.77 | 11.26 | |||||
Cash From Operations, 2 Yr. CAGR % | 8.73 | -38.16 | 29.62 | -6.76 | -78.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | -23.96 | -15.36 | -20.93 | 2.07 | 7.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -43.47 | -42.27 | 34.72 | -1.1 | -51.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -37.9 | -39.49 | 40.73 | 5.73 | -80.68 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.91 | 7.07 | 12.38 | 7.03 | -1.95 | |||||
Gross Profit, 3 Yr. CAGR % | 4.9 | 19.88 | 7.21 | 5.72 | -14.28 | |||||
EBITDA, 3 Yr. CAGR % | -8.39 | 35.91 | 25.06 | 5.22 | -34.91 | |||||
EBITA, 3 Yr. CAGR % | -10.28 | 46.82 | 29.39 | 10.52 | -38.42 | |||||
EBIT, 3 Yr. CAGR % | -13.02 | 46.93 | 34.52 | 8.09 | -44.68 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -9.66 | -2.32 | 37.94 | -63.31 | -13.96 | |||||
Net Income, 3 Yr. CAGR % | -23.2 | -13.95 | 93.86 | -41.84 | -4.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | -24.59 | 144.94 | 52.25 | 1.18 | -21.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -23.38 | -14.2 | 93.77 | -41.81 | -4.7 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.8 | -0.86 | 5.43 | 3 | -4.39 | |||||
Inventory, 3 Yr. CAGR % | -55.48 | -31.73 | -5.9 | -20.63 | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 77.8 | -5.95 | -15.93 | -13.56 | -14.06 | |||||
Total Assets, 3 Yr. CAGR % | 9.15 | 7.08 | 2.37 | 1.77 | -2.76 | |||||
Tangible Book Value, 3 Yr. CAGR % | 191.91 | 67.62 | 19.13 | 4.36 | -6.31 | |||||
Common Equity, 3 Yr. CAGR % | -12.24 | -7.3 | 2.81 | 10.28 | 10.7 | |||||
Cash From Operations, 3 Yr. CAGR % | 479.16 | 25.61 | -25.51 | 10.55 | -63.32 | |||||
Capital Expenditures, 3 Yr. CAGR % | -20.95 | -15.91 | -24.2 | 2.32 | -10.92 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 9.91 | -19.56 | -28.12 | 16.79 | -35.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.2 | -14.69 | -23.34 | 21.63 | -64.19 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.88 | 6.54 | 6.27 | 4.34 | 4.92 | |||||
Gross Profit, 5 Yr. CAGR % | 10.36 | 9.17 | 10.45 | 8.15 | -5.59 | |||||
EBITDA, 5 Yr. CAGR % | 5.57 | 2.59 | 2.67 | 16.67 | -13.23 | |||||
EBITA, 5 Yr. CAGR % | 4.46 | 2.7 | 2.59 | 20.47 | -15.66 | |||||
EBIT, 5 Yr. CAGR % | 2.37 | 1 | 2.02 | 21.5 | -17.98 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.84 | -8.15 | -17.06 | -42.45 | 18.04 | |||||
Net Income, 5 Yr. CAGR % | -1.78 | -11.73 | -16.93 | -33.47 | 47.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | -5.82 | -4.57 | -7.54 | 55.92 | 12.34 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.94 | -11.81 | -17.02 | -33.55 | 47.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.19 | -4.35 | -0.55 | -1.6 | 0.95 | |||||
Inventory, 5 Yr. CAGR % | 5.92 | 10.07 | -40.67 | -38.1 | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 59.2 | 43.1 | 32.04 | -9.73 | -13.88 | |||||
Total Assets, 5 Yr. CAGR % | 10.15 | 10.42 | 7 | 2.97 | 0.45 | |||||
Tangible Book Value, 5 Yr. CAGR % | 90.46 | 58.86 | 101.66 | 32.22 | 6.56 | |||||
Common Equity, 5 Yr. CAGR % | -2.07 | -4.18 | -5.15 | 0.61 | 6.11 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.38 | 69.4 | 223.07 | 11.49 | -54.8 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.81 | -8.43 | -20.94 | -9.13 | -12.72 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 129.61 | 148.23 | 19.23 | -12.63 | -38.39 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 67.91 | 78.94 | 21.52 | -7.04 | -55.83 |
- Stock Market
- Stocks
- ALKEY Stock
- Financials Keyrus
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















